By James
Gutman - August 20, 2015
Maryland, where I reside, is a strange
state in many ways, and especially when it comes to both Medicare Advantage
(MA) and hospitals. In Medicare, managed care penetration has been dismal, with
the most popular product not even really an MA one but instead a
five-star-rated Kaiser Permanente cost plan. In hospitals, which by Maryland
law have to be not-for-profit, the state until the beginning of last year had
perhaps the tightest regulation of charges in the nation. Now, however, both of
those things have changed dramatically, and the result may be an interesting
experiment in what inroads providers can make in owning MA plans.
It all started coming to a head in
January 2014, when Maryland hospitals began a five-year global-budgeting
demonstration program with the backing of the CMS Center for Medicare and
Medicaid Innovation. The hospitals, in effect, get a fixed amount of money to
serve their Medicare population and thus are fully at risk if that costs more
than they are paid. This gives them a powerful incentive to improve population
health and manage care. And it therefore gives them a big reason to embrace MA
as a way to get better data, gain access to CMS star-rating bonuses and make
use of beneficiary and provider incentives.
The implications of this were not lost
on the state’s hospitals, which even before that had begun forming themselves
into major health systems. One is MedStar Health, which includes such
well-regarded facilities as Georgetown University Hospital, and it began in
2013 with the help of the partly provider-owned Evolent Health advisory firm,
to develop MA plans. By this year, it was up to about 8,000 MA members. This
success was not lost on the other growing hospital alliances, including John
Hopkins HealthCare, which intends to start owning MA plans next year, as
reportedly does its biggest in-state rival, the University of Maryland Medical
System (UMMS). Nor are smaller systems left out, as several of them this
February launched Advanced Health Collaborative, LLC, which acknowledges that
it may launch MA products on behalf of some or all of its members in 2016 or
2017.
But it gets more interesting. Hopkins
and UMMS, which are clear competitors albeit not of the “Hatfields-and-McCoys”
variety like Pittsburgh-based Highmark Health and UPMC (which perhaps
coincidentally is a joint-venture partner in Evolent Health), won’t have the
other’s system in their MA products. And Hopkins will start with just MA PPOs,
which could be a sharp contrast with Kaiser Permanente’s MA product structure.
What do you think about all these
provider-owned MA products in the works in Maryland? Is this a good development
for the industry — and for Medicare beneficiaries? Can they all be successful?
What will this mean for the other MA plans in the state and for MA penetration?
And is Maryland, which bills itself as The Free State, in its burgeoning
provider-owned MA a harbinger of the future in MA or just an anomaly as usual?
http://aishealth.com/blog/medicare-advantage-and-part-d/would-you-believe-four-new-health-system-owned-ma-product-lines-o?utm_source=Real%20Magnet&utm_medium=Email&utm_campaign=80514069
No comments:
Post a Comment